Johnson & Johnson Stock Stumbles As Lowered Profit View Outweighs Q3 Earnings Beat: Retail Stays Optimistic

Barchart · 10/15 09:30
Johnson & Johnson lowered its full year guidance to account for the acquisition of V-Wave, which is developing an implanted device for heart failure.